The $379 Million Disaster: Why New York's Big Spenders Are Already Choking in April

The first month of baseball is supposed to be noise. A mirage. A statistical blip that tells you almost nothing about October.

Except when it tells you everything.

Jeff Passan's deep dive into April's early takeaways reveals something ugly lurking beneath the surface: the most expensive teams in baseball are tanking, and the league is watching it happen in real time. The New York Mets, sitting at a bloated $379.3 million payroll, have limped to a 10-20 record. The Philadelphia Phillies, with $315.1 million committed, are 10-19. The Boston Red Sox, $268 million invested, check in at 12-19. These aren't budget teams trying to scrape together a roster. These are financial commitments the size of small countries, and they're producing September-level results in late April.

The Winners and Losers Tell the Real Story

Here's what's wild: of the dozen teams that made the playoffs last year, nine have stayed competitive through April. The Dodgers ($416.8 million) and Yankees ($338.7 million) are both sitting pretty at 20-11. The Padres, with a modest $258.6 million, are 19-11. So money isn't broken. It's just that when you spend it badly, April doesn't care how big your wallet is.

The data backs this up. Seven of the top 12 players in FanGraphs wins above replacement through April stayed elite all the way through the season last year. Translation: if you're crushing it early, you're probably crushing it in September too. The inverse is equally terrifying: failure in April threatens to torpedo entire seasons.

April's Weird Reality Check

The 2026 season has been a funhouse mirror. Every single team in the National League Central is above .500. Starting pitchers, as a group, have posted better ERA numbers than relief pitchers. Shohei Ohtani is pitching better than he's hitting. It's chaos.

But here's the thing: elite in April often means elite for the rest of the year. The Mets, Phillies, and Red Sox have time to turn this around. They're not dead yet. But they're also not in the "small sample size" excuse territory anymore. They're in the "we spent a fortune and we're still losing" territory. That's a different kind of problem entirely.

Watch what these teams do next. That's where the real story lives.

This article was created with AI assistance and reviewed by Seattle On Tap editorial staff. Always verify information with official team sources.